The evolutionary neuroanthropology of consciousness : exploring the diversity of conscious states across cultures. An interview with Michael Winkelman. Michael Winkelman & Martin E. Fortier ALIUS Bulletin, 2019, 3, 45-97. doi : 10.34700/krg3-zk35 Abstract In this interview, Michael Winkelman and Martin Fortier discuss the extent to which consciousness is grounded in deep evolutionary mechanisms and can be enculturated. First, the main tenets of two neuroanthropological approaches to consciousness and culture are outlined. Next, the upsides and downsides of evolutionary psychology are examined; the fruitfulness of this approach in the study of cultural phenomena such as shamanism is debated. The authors then discuss the promises of [...]
Lire la suiteSense of reality, metacognition and culture in schizophrenic and drug-induced hallucinations : An interdisciplinary approach Martin Fortier In J. Proust & M. Fortier (Eds.) : "Metacognitive Diversity : An Interdisciplinary Approach", 2018. Oxford/New York, Oxford University Press. Abstract Hallucinations possess two main components : (i) a sensory content; and (ii) a sense that the sensory content is real. Influential models of schizophrenic hallucination claim that both the sensory content and the sense of reality can be explained in terms of metacognitive dysfunction. This chapter assesses whether such a claim holds for schizophrenic and drug-induced hallucinations; it further attempts to determine the actual role of metacognition [...]
Lire la suiteChapter 12 : Gnosis Potency : DMT Breakthroughs and Paragnosis Graham St John in B. C. Labate, C. Cavnar (eds.), "Plant Medicines, Healing and Psychedelic Science", Springer International Publishing AG, part of Springer Nature 2018 doi : 10.1007/978-3-319-76720-8_12 Abstract DMT (N,N-dimethyltryptamine) is a powerful tryptamine that has experienced growing appeal in the last decade, independent from ayahuasca, the Amazonian visionary brew in which it is an integral ingredient. Investigating user reports available from literary and online sources, this chapter focuses on the gnosis potency associated with the DMT “breakthrough” experience. I explore the parameters of the tryptaminal state and, in particular, the extraordinary paragnosis associated with [...]
Lire la suiteExploring ayahuasca-assisted therapy for addiction: A qualitative analysis of preliminary findings among an Indigenous community in Canada Elena ARGENTO, Rielle CAPLER, Gerald THOMAS, Philippe LUCAS & Kenneth W. TUPPER Drug and Alcohol Review, 2019 Doi : 10.1111/dar.12985 Abstract Introduction and Aims. A previous observational study of ayahuasca-assisted therapy demonstrated statistically significant reductions in self-reported problematic cocaine use among members of an Indigenous community in Canada. This paper aims to qualitatively explore the impact of ayahuasca assisted therapy on addiction and other substance use-related outcomes and elucidate the lived experiences of participants. Design and Methods. Qualitative interviews were conducted with 11 adult Indigenous participants of the ayahuasca-assisted [...]
Lire la suitePsychedelics in History and World Religions, Editorial Michael James Winkelman Journal of Psychedelic Studies, 2019, 3, (2), pp. 41–42 Doi : 10.1556/2054.2019.021 Recent research has given new hope that psychedelics might provide important tools for treating some of our more intractable ailments. Assessment of the therapeutic applications of psychedelics for various conditions (Winkelman & Sessa, 2019) offers tantalizing promises of what may be seen as miracle cures for their immediate results and effectiveness. As new technologies expand our understandings of the effects of these substances, we are entering a new epoch of understanding the systemic effects of psychedelics on the brain. These findings regarding the [...]
Lire la suiteTherapeutic Bases of Psychedelic Medicines : Psycho-integrative Effects Michael J. WINKELMAN chapter 1, in "PSYCHEDELIC MEDICINE: SOCIAL, CLINICAL, AND LEGAL PERSPECTIVES" january 2007, pp 1-19. INTRODUCTION For thousands of years, human beings have used medicinal plants to enhance their health and well-being. In cultures around the world, plants commonly referred to as psychedelic, hallucinogens, and entheogens have played central roles in their healing practices. These vision-inducing plants have also played important roles in the religious and spiritual practices of many societies, evoking powerful emotional, cognitive, and therapeutic reactions. These plants that were central to concepts of health, spirituality, and well-being were, however, demonized and rejected [...]
Lire la suiteÉtudes psychédéliques Vincent Verroust, doctorant à l'EHESS ( CAK )Cet enseignant est référent pour cette UE https://enseignements-2019.ehess.fr/2019/ue/2998/ Mardi de 18 h à 19 h 30 (amphithéâtre Rouelle, Muséum national d'Histoire naturelle, 57 rue Cuvier 75005 Paris), les 26 novembre, 17 décembre 2019, 28 janvier, 25 février, 31 mars, 28 avril, 26 mai et 30 juin 2020 Plan pour trouver l'amphi : https://drive.google.com/file/d/1h-oVy6oTh7UTMh84X-o448VhCCmBMp-M/view?usp=sharing NB : merci d'arriver en avance pour éviter de trouver portes closes. Le terme psychedelic a été forgé en 1956 par le psychiatre britannique Humphry Osmond (1917 - 2004) pour qualifier les effets psychiques de la mescaline et du LSD, deux substances psychotropes sur lesquelles [...]
Lire la suiteBIBLIOGRAPHIE : Psilocybes, psilocybine. Dr Christian SUEUR, GRECC, décembre 2019 Psilocybes, psilocybine : généralités ..............................1 Psilocybes : ethnologie ...................................................2 Psilocybine : clinique psychiatrique ..............................4 Psilocybine : pharmacologie ..........................................5 Psilocybine : toxicologie - "effets indésirables" .............7 Psilocybine : neurophysiologie ......................................9 Psilocybine : expériences mystiques .............................13 Psilocybine : thérapie psychédélique ............................15-19
Lire la suiteThe psychedelic renaissance : the next trip for psychiatry ? J. R. Kelly, A. Baker, M. Babiker, L. Burke, C. Brennan and V. O’Keane Irish Journal of Psychological Medicine, 2019, 1 - 5 doi : 10.1017/ipm.2019.39 Abstract The psychedelic research renaissance is gaining traction. Preliminary clinical studies of the hallucinogenic fungi, psilocybin, with psychological support, have indicated improvements in mood, anxiety and quality of life. A seminal, open-label study demonstrated marked reductions in depression symptoms in participants with treatment-resistant depression (TRD). The associated neurobiological processes involve alterations in brain connectivity, together with altered amygdala and default mode network activity. At the cellular level, psychedelics promote [...]
Lire la suitePsychedelic Experiential Pharmacology : Pioneering Clinical Explorations with Salvador Roquet (How I Came to All of This : Ketamine, Admixtures and Adjuvants, Don Juan and Carlos Castaneda Too) An Interview with Richard Yensen Philip E. Wolfson International Journal of Transpersonal Studies, 2014, 33, (2), 160-174. Richard Yensen was a research fellow at the Maryland Psychiatric Research Center from 1972 to 1976. He studied psychedelic psychotherapy with Stanislav Grof, M.D. and other senior staff. During this time he treated patients with substance abuse disorders, cancer, neurosis, and other health professionals seeking a training experience. Dr. Yensen did his Ph.D. dissertation on the use of MDA in [...]
Lire la suite